GlassScriptPhysician profile
William H Haynie
NPI 1588664080
$7,678.47
in general payments reported to CMS, 2019-2025
35 companies · $1,284 in 2025
The $1,284 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $584 · 2020: $241 · 2021: $1,864 · 2022: $739 · 2023: $1,169 · 2024: $1,797 · 2025: $1,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,230 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,229.86 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,249.68 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $806.85 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $618.01 | 2019-2025 | Emblem Mri S-Icd, General - Tachy |
| Abiomed | $611.51 | 2022-2025 | Impella |
| Medtronic, INC. | $505.60 | 2021-2024 | Onyx Frontier, Micra |
| Kestra Medical Technology Services, INC. | $434.38 | 2024-2025 | Assure Wcd |
| Inari Medical, INC. | $374.86 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $332.60 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $272.06 | 2020-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $248.85 | 2024-2025 | Eliquis, Camzyos |
| Amgen INC. | $248.73 | 2019-2024 | Repatha |
| Silk Road Medical, INC. | $243.67 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.28 | 2023-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $189.43 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $167.76 | 2022-2025 | Farxiga, Lokelma |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $150.54 | 2024 | Inpefa |
| Heartflow, INC. | $110.00 | 2021 | |
| Esperion Therapeutics, INC. | $105.01 | 2023-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $95.39 | 2019-2024 | |
| Daiichi Sankyo INC. | $80.81 | 2022-2024 | Injectafer |
| Itamar Medical INC | $61.18 | 2023-2025 | Watchpatone |
| Stryker Corporation | $60.81 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $59.92 | 2024-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Coronary, Xience Skypoint |
| Bayer Healthcare Pharmaceuticals INC. | $59.06 | 2025 | |
| Philips North America LLC | $58.05 | 2019-2025 | Ecc Solutions |
| Cordis US Corp. | $57.84 | 2024 | Mynx Control, Rain Sheath, Elitecross |
| Inspire Medical Systems, INC. | $46.91 | 2025 | Inspire |
| Novo Nordisk INC | $36.78 | 2024 | Rybelsus, Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $36.17 | 2024 | Verquvo |
| Cvrx, INC. | $22.83 | 2023 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $22.13 | 2025 | Evkeeza |
| Baxter Healthcare | $22.11 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Lilly USA, LLC | $18.61 | 2025 | Mounjaro, Zepbound |
| Kiniksa Pharmaceuticals, LTD. | $18.48 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $13.57 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Haynie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.